{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:41:48Z","timestamp":1767789708092,"version":"3.49.0"},"reference-count":44,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jmsacl.2022.12.003","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T12:03:52Z","timestamp":1670846632000},"page":"7-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Validation of a quantitative multiplex LC-MS\/MS assay of carvedilol, enalaprilat, and perindoprilat in dried blood spots from heart failure patients and its cross validation with a plasma assay"],"prefix":"10.21627","volume":"27","author":[{"given":"Andre","family":"Joubert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marthinus","family":"van der Merwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Castel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Denti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Sliwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phumla","family":"Sinxadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4811","reference":[{"key":"10.1016\/j.jmsacl.2022.12.003_b0005","doi-asserted-by":"crossref","unstructured":"G. Lippi, F. Sanchis-Gomar, Global epidemiology and future trends of heart failure, AME Med. J. 5 (2020) 15\u201315. https:\/\/doi.org\/10.21037\/amj.2020.03.03.","DOI":"10.21037\/amj.2020.03.03"},{"key":"10.1016\/j.jmsacl.2022.12.003_b0010","first-page":"141","article-title":"Explaining heart failure hyper-mortality in Sub Saharan Africa: global genomic and environmental contribution review","volume":"112","author":"Ajayi","year":"2020","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0015","first-page":"86","article-title":"Medication adherence, self-care behaviour and knowledge on heart failure in urban South Africa: the Heart of Soweto study","volume":"21","author":"Ruf","year":"2010","journal-title":"Cardiovasc J. Afr."},{"issue":"5","key":"10.1016\/j.jmsacl.2022.12.003_b0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/phar.2107","article-title":"Association between medication adherence and the outcomes of heart failure","volume":"38","author":"Hood","year":"2018","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0025","first-page":"1","article-title":"Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta-analysis of controlled trials","volume":"10","author":"Ruppar","year":"2016","journal-title":"J. Amercian Hear. Assoc."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/RRCC.S50658","article-title":"Improving medication adherence of patients with chronic heart failure: challenges and solutions","author":"Shah","year":"2015","journal-title":"Res. Reports Clin. Cardiol."},{"issue":"1-2","key":"10.1016\/j.jmsacl.2022.12.003_b0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jchromb.2005.06.012","article-title":"Quantification of carvedilol in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: Application to bioequivalence study","volume":"822","author":"do Carmo Borges","year":"2005","journal-title":"J. Chromatogr. B Anal. Technol. Biomed Life Sci."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.amjcard.2006.07.015","article-title":"Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension","volume":"98","author":"Henderson","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.0000075957.16003.07","article-title":"What is an angiotensin converting enzyme inhibitor?","volume":"108","author":"Sweitzer","year":"2003","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.jmsacl.2022.12.003_b0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10337-022-04154-y","article-title":"Simultaneous Determination of Carvedilol, Enalaprilat, and Perindoprilat in Human Plasma Using LC \u2013 MS \/ MS and Its Application to a Pharmacokinetic Pilot Study","volume":"85","author":"Joubert","year":"2022","journal-title":"Chromatographia."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0055","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4155\/bio.10.158","article-title":"The application of dried blood spot sampling in global clinical trials","volume":"2","author":"Van Amsterdam","year":"2010","journal-title":"Bioanalysis."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0060","unstructured":"Neoteryx, neotryx website, (n.d.). https:\/\/www.neoteryx.com\/microsampling-blog\/why-use-dried-blood-tests-vs-wet-blood-tests- (accessed October 14, 2021)."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12981-017-0138-y","article-title":"Comparison of six methods to estimate adherence in an ART-na\u00efve cohort in a resource-poor setting: Which best predicts virological and resistance outcomes?","volume":"14","author":"Orrell","year":"2017","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0070","doi-asserted-by":"crossref","first-page":"9395","DOI":"10.1021\/acs.analchem.8b02046","article-title":"Dried-blood-spot technique to monitor direct oral anticoagulants: clinical validation of a UPLC-MS\/MS-Based Assay","volume":"90","author":"Foerster","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2019.121897","article-title":"Vancomycin and creatinine determination in dried blood spots: Analytical validation and clinical assessment","volume":"1137","author":"Scribel","year":"2020","journal-title":"J. Chromatogr. B Anal. Technol. Biomed Life Sci."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0080","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4269\/ajtmh.17-0889","article-title":"Review article: dried blood spots for global health diagnostics and surveillance: opportunities and challenges","volume":"99","author":"Lim","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0085","first-page":"288","article-title":"Advantages and challenges of dried blood spot analysis by mass spectrometry across the total testing process","volume":"27","author":"Zakaria","year":"2016","journal-title":"J. Int. Fed. Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0090","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/FTD.0000000000000703","article-title":"Clinical validation of a dried blood spot assay for 8 antihypertensive drugs and 4 active metabolites","volume":"42","author":"Peeters","year":"2020","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0095","doi-asserted-by":"crossref","unstructured":"M. Mazzarino, L. Di Costanzo, F. Comunita, C. Stacchini, X. De Torre, F. Botre, UHPLC \u2212 HRMS Method for the Simultaneous Screening of 235 Drugs in Capillary Blood for Doping Control Purpose\u00a0: Comparative Evaluation of Volumetric and Non-volumetric Dried Blood Spotting Devices, (2022). https:\/\/doi.org\/10.1021\/acsomega.2c01417.","DOI":"10.1021\/acsomega.2c01417"},{"key":"10.1016\/j.jmsacl.2022.12.003_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339137","article-title":"Evaluation and analytical applicability of a novel volumetric absorptive microsampling strategy for adherence monitoring of antihypertensive drugs by means of LC-HRMS\/MS","volume":"1187","author":"Jacobs","year":"2021","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0105","first-page":"1","article-title":"Dried blood spot technique-based liquid chromatography-tandem mass spectrometry method as a simple alternative for benznidazole pharmacokinetic assessment","volume":"62","author":"Bedor","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0110","first-page":"1","author":"Zheng","year":"2015","journal-title":"NIH Public Access"},{"key":"10.1016\/j.jmsacl.2022.12.003_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/828719","article-title":"Dried blood spot sampling with LC-MS analysis for routine therapeutic caffeine monitoring in neonates dried blood spot sampling with LC-MS analysis for","volume":"2012","author":"Lawson","year":"2012","journal-title":"ISRN Chromatogr."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0120","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jfda.2019.06.001","article-title":"Simultaneous determination of cardiovascular drugs in dried blood spot by liquid chromatography-tandem mass spectrometry","volume":"27","author":"Kim","year":"2019","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0125","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3923\/ajsr.2018.232.239","article-title":"Research article analysis of rifampicin in dried blood spots using high performance liquid chromatography","volume":"11","author":"Harahap","year":"2018","journal-title":"Asian J. Sci. Res."},{"issue":"2","key":"10.1016\/j.jmsacl.2022.12.003_b0130","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00216-010-3571-5","article-title":"Development and validation of a dried blood spot \u2013 HPLC assay for the determination of metronidazole in neonatal whole blood samples","volume":"397","author":"Suyagh","year":"2010","journal-title":"Anal Bioanal Chem."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpba.2017.10.030","article-title":"Validation of an LC\u2013MS\/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots","volume":"149","author":"Schauer","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0140","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.2147\/IJGM.S312633","article-title":"Development and validation of a simple and sensitive LC-MS\/MS method for quantification of metformin in dried blood spot its application as an indicator for medication adherence","volume":"14","author":"Alquadeib","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0145","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1080\/00032719.2017.1302461","article-title":"Quantification of polycyclic aromatic hydrocarbons in avian dried blood spots by ultra-performance liquid chromatography with simple liquid extraction and phospholipid solid-phase extraction preparation","volume":"50","author":"Provatas","year":"2017","journal-title":"Anal. Lett."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0150","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0155","series-title":"Exploratory Data Analysis","author":"Tukey","year":"1977"},{"key":"10.1016\/j.jmsacl.2022.12.003_b0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/clinchem\/46.1.100","article-title":"General deming regression for estimating systematic bias and its confidence interval in method-comparison studies","volume":"46","author":"Martin","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0165","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/AAC.02976-15","article-title":"Validation and clinical evaluation of a novel method to measure miltefosine in leishmaniasis patients using dried blood spot sample collection","volume":"60","author":"Kip","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0170","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/jphp.12757","article-title":"Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood sampling","volume":"69","author":"Boons","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0175","unstructured":"EMA, (n.d.). https:\/\/www.ema.europa.eu\/en (accessed June 11, 2020)."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jcp.s1-5.1.5","article-title":"Plasma triglyceride metabolism","author":"Robinson","year":"1973","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0185","unstructured":"FDA, Bioanalytical Method Validation Guidance, (n.d.). https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioanalytical-method-validation-guidance-industry."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0190","first-page":"1","article-title":"The comparison of morbid obesity quality of life and body image between surgery and other treatments: A case \u2013 control study","author":"Yazdani","year":"2020","journal-title":"J. Educ Health Promot."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/2327-6924.12510","article-title":"Obesity: Risk factors, complications, and strategies for sustainable long-term weight management","volume":"29","author":"Fruh","year":"2017","journal-title":"J. Am. Assoc. Nurse Pract."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0200","first-page":"152","article-title":"Pharmacokinetics in obese patients","volume":"4","author":"De Baerdemaeker","year":"2004","journal-title":"Contin. Educ. Anaesthesia, Crit. Care Pain."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/00365513.2019.1622033","article-title":"Hematocrit effect on dried blood spots in adults: a computational study and theoretical considerations","volume":"79","author":"Daousani","year":"2019","journal-title":"Scand. J. Clin Lab. Invest."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0210","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2710.2005.00646.x","article-title":"Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays","volume":"30","author":"Arafat","year":"2005","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2257.2003.00484.x","article-title":"Significant differences between capillary and venous complete blood counts in the neonatal period","volume":"25","author":"Kayiran","year":"2003","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/j.jmsacl.2022.12.003_b0220","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jpha.2018.05.004","article-title":"Simultaneous determination of indapamide, perindopril and perindoprilat in human plasma or whole blood by UPLC-MS\/MS and its pharmacokinetic application","volume":"8","author":"Tao","year":"2018","journal-title":"J. Pharm. Anal."}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X22000451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X22000451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:38Z","timestamp":1767770558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X22000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":44,"alternative-id":["S2667145X22000451"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2022.12.003","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of a quantitative multiplex LC-MS\/MS assay of carvedilol, enalaprilat, and perindoprilat in dried blood spots from heart failure patients and its cross validation with a plasma assay","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2022.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}